参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/06 | 1,105 | 1,115 | 1,099 | 1,113 | -1 | -0.1% | 1,362,300 |
2023/04/05 | 1,138 | 1,139 | 1,112 | 1,114 | -25 | -2.2% | 1,348,900 |
2023/04/04 | 1,130 | 1,151 | 1,125 | 1,139 | +13 | +1.2% | 1,654,400 |
2023/04/03 | 1,138 | 1,142 | 1,120 | 1,126 | -4 | -0.4% | 999,000 |
2023/03/31 | 1,113 | 1,133 | 1,112 | 1,130 | +11 | +1% | 1,705,300 |
2023/03/30 | 1,130 | 1,130 | 1,114 | 1,119 | -20 | -1.8% | 1,319,700 |
2023/03/29 | 1,132 | 1,141 | 1,121 | 1,139 | +7 | +0.6% | 1,749,300 |
2023/03/28 | 1,145 | 1,148 | 1,121 | 1,132 | -10 | -0.9% | 1,977,200 |
2023/03/27 | 1,127 | 1,147 | 1,118 | 1,142 | +30 | +2.7% | 2,225,000 |
2023/03/24 | 1,095 | 1,117 | 1,082 | 1,112 | +22 | +2% | 2,047,200 |
2023/03/23 | 1,093 | 1,101 | 1,089 | 1,090 | -11 | -1% | 1,592,800 |
2023/03/22 | 1,105 | 1,115 | 1,097 | 1,101 | +18 | +1.7% | 2,342,600 |
2023/03/20 | 1,116 | 1,117 | 1,083 | 1,083 | -30 | -2.7% | 2,226,300 |
2023/03/17 | 1,084 | 1,120 | 1,076 | 1,113 | +42 | +3.9% | 3,470,100 |
2023/03/16 | 1,048 | 1,079 | 1,045 | 1,071 | +17 | +1.6% | 2,261,100 |
2023/03/15 | 1,041 | 1,060 | 1,041 | 1,054 | +19 | +1.8% | 1,430,000 |
2023/03/14 | 1,035 | 1,038 | 1,025 | 1,035 | -13 | -1.2% | 1,740,300 |
2023/03/13 | 1,057 | 1,058 | 1,041 | 1,048 | -13 | -1.2% | 1,315,100 |
2023/03/10 | 1,064 | 1,070 | 1,060 | 1,061 | -6 | -0.6% | 1,653,800 |
2023/03/09 | 1,058 | 1,071 | 1,055 | 1,067 | +5 | +0.5% | 1,076,700 |
2023/03/08 | 1,049 | 1,067 | 1,048 | 1,062 | +11 | +1% | 1,417,800 |
2023/03/07 | 1,047 | 1,064 | 1,043 | 1,051 | +2 | +0.2% | 1,762,600 |
2023/03/06 | 1,043 | 1,053 | 1,038 | 1,049 | +9 | +0.9% | 2,130,300 |
2023/03/03 | 1,011 | 1,042 | 1,009 | 1,040 | +24 | +2.4% | 4,115,800 |
2023/03/02 | 1,019 | 1,029 | 1,013 | 1,016 | -6 | -0.6% | 2,986,400 |
2023/03/01 | 1,036 | 1,037 | 1,021 | 1,022 | -18 | -1.7% | 1,847,300 |
2023/02/28 | 1,050 | 1,053 | 1,037 | 1,040 | -14 | -1.3% | 1,979,800 |
2023/02/27 | 1,052 | 1,061 | 1,045 | 1,054 | +3 | +0.3% | 1,861,700 |
2023/02/24 | 1,043 | 1,056 | 1,039 | 1,051 | +17 | +1.6% | 2,144,700 |
2023/02/22 | 1,047 | 1,050 | 1,026 | 1,034 | -8 | -0.8% | 1,868,800 |
2023/02/21 | 1,025 | 1,046 | 1,019 | 1,042 | +36 | +3.6% | 2,690,800 |
2023/02/20 | 1,003 | 1,007 | 999 | 1,006 | +11 | +1.1% | 845,600 |
2023/02/17 | 991 | 998 | 989 | 995 | -6 | -0.6% | 2,018,000 |
2023/02/16 | 999 | 1,001 | 993 | 1,001 | +2 | +0.2% | 1,741,300 |
2023/02/15 | 1,020 | 1,021 | 998 | 999 | -16 | -1.6% | 1,296,300 |
2023/02/14 | 1,015 | 1,019 | 1,010 | 1,015 | +7 | +0.7% | 1,486,700 |
2023/02/13 | 1,008 | 1,012 | 1,002 | 1,008 | +6 | +0.6% | 1,272,900 |
2023/02/10 | 994 | 1,003 | 987 | 1,002 | ±0 | ±0% | 1,410,300 |
2023/02/09 | 1,009 | 1,012 | 999 | 1,002 | -12 | -1.2% | 1,785,300 |
2023/02/08 | 987 | 1,015 | 983 | 1,014 | +23 | +2.3% | 2,604,800 |
2023/02/07 | 993 | 995 | 988 | 991 | ±0 | ±0% | 2,282,200 |
2023/02/06 | 995 | 998 | 987 | 991 | +4 | +0.4% | 2,077,900 |
2023/02/03 | 998 | 1,004 | 984 | 987 | -19 | -1.9% | 2,875,900 |
2023/02/02 | 1,007 | 1,012 | 1,003 | 1,006 | -1 | -0.1% | 1,999,700 |
2023/02/01 | 1,011 | 1,017 | 1,007 | 1,007 | -3 | -0.3% | 2,084,200 |
2023/01/31 | 1,014 | 1,019 | 1,005 | 1,010 | +5 | +0.5% | 1,991,900 |
2023/01/30 | 1,000 | 1,012 | 998 | 1,005 | -1 | -0.1% | 3,950,300 |
2023/01/27 | 1,008 | 1,024 | 1,005 | 1,006 | -2 | -0.2% | 3,233,400 |
2023/01/26 | 1,019 | 1,023 | 1,006 | 1,008 | -14 | -1.4% | 2,081,500 |
2023/01/25 | 1,019 | 1,025 | 1,008 | 1,022 | +3 | +0.3% | 1,967,100 |
551~
600
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,300円 | -2.0% | -7.3% | 2.27% | 16.59倍 | 1.97倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
エーザイ | 413,000円 | +0.1% | -3.4% | 3.87% | 28.08倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 158,400円 | +0.6% | +43.3% | 5.05% | 11.11倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 206,800円 | +8.4% | +0.2% | 2.03% | 15.03倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 89,500円 | -11.0% | +206.6% | 0.00% | 8.89倍 | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム